Surface Display of Cholera Toxin B Subunit Recombinant Escherichia coli Ghosts Further Enhances Resistance to Chlamydia abortus Infection in Mice
- PMID: 39203498
- PMCID: PMC11356887
- DOI: 10.3390/microorganisms12081656
Surface Display of Cholera Toxin B Subunit Recombinant Escherichia coli Ghosts Further Enhances Resistance to Chlamydia abortus Infection in Mice
Abstract
Chlamydia abortus (C. abortus) is an important zoonotic pathogen that seriously endangers the development of animal husbandry. Vaccination is the most effective approach to preventing C. abortus infection. We previously reported a recombinant Escherichia coli ghost (rECG)-based C. abortus vaccine that demonstrated outstanding protective efficacy. In this study, we further attempted to fuse the cholera toxin B subunit (CTB), a widely studied potent mucosal immune adjuvant, with macrophage infectivity potentiator (MIP), a candidate antigen of C. abortus, on the surface of the rECG and explore its protective effect against C. abortus infection. The MIP fusion protein was highly expressed in the rECGs, and the CTB-modified rECGs significantly induced the activation of mouse bone marrow-derived dendritic cells in vitro. Intranasal immunization with rECGs induced a Th1-biased cellular immune response. Compared to the rECGs without CTB, the CTB-modified rECGs induced higher concentrations of IgA in the serum and vaginal wash solution. Moreover, in a mouse infection model, the CTB-modified rECGs significantly improved the clearance efficiency of C. abortus and reduced the pathological damage to the uterus. This study demonstrates that incorporating CTB into rECGs significantly enhances the immunogenic potential of the rECG vaccine and can significantly enhance its protective efficacy against a C. abortus challenge.
Keywords: CTB; Chlamydia abortus; bacterial ghost; mucosal immunity; vaccine.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Bacterial ghosts engineered with lipidated antigens as an adjuvant-free vaccine for Chlamydia abortus.Int J Pharm. 2024 Dec 5;666:124801. doi: 10.1016/j.ijpharm.2024.124801. Epub 2024 Oct 4. Int J Pharm. 2024. PMID: 39368676
-
Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model.Vaccine. 2015 Apr 8;33(15):1865-72. doi: 10.1016/j.vaccine.2015.02.007. Epub 2015 Feb 17. Vaccine. 2015. PMID: 25698486 Free PMC article.
-
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.Infect Immun. 1993 Jan;61(1):314-22. doi: 10.1128/iai.61.1.314-322.1993. Infect Immun. 1993. PMID: 8418053 Free PMC article.
-
Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.Am J Trop Med Hyg. 1994;50(5 Suppl):42-54. Am J Trop Med Hyg. 1994. PMID: 8203723 Review.
-
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.Immunol Lett. 2005 Mar 15;97(2):181-8. doi: 10.1016/j.imlet.2004.11.009. Epub 2004 Dec 7. Immunol Lett. 2005. PMID: 15752556 Review.
Cited by
-
CD40 Ligand Potentiates Immunogenecity of Mycoplasma pneumoniae Subunit Vaccine Candidate in a Murine Model.Curr Issues Mol Biol. 2025 Jan 9;47(1):37. doi: 10.3390/cimb47010037. Curr Issues Mol Biol. 2025. PMID: 39852152 Free PMC article.
References
-
- Essig A., Longbottom D. Chlamydia abortus: New Aspects of Infectious Abortion in Sheep and Potential Risk for Pregnant Women. Curr. Clin. Microbiol. Rep. 2015;2:22–34. doi: 10.1007/s40588-015-0014-2. - DOI
-
- Longbottom D., Sait M., Livingstone M., Laroucau K., Sachse K., Harris S.R., Thomson N.R., Seth-Smith H.M.B. Genomic Evidence That the Live Chlamydia abortus Vaccine Strain 1B Is Not Attenuated and Has the Potential to Cause Disease. Vaccine. 2018;36:3593–3598. doi: 10.1016/j.vaccine.2018.05.042. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous